Bristol Myers Squibb
Princeton, NJ, United States
Vice President & Disease Area Head, Rheumatology and Dermatology at Bristol Myers Squibb,
0261: Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure information not submitted.
